Estimating the future course of cancer is invaluable to physicians; however, current clinical methods fail to effectively use the vast amount of multimodal data that is available for cancer patients.
heterogeneity and high dimensionality of the available data. For example, each patient 25 in the TCGA database has thousands of genomic features (e.g. microRNA or mRNA) 26 and high resolution histopathology whole slide images (WSIs). Yet, based on previous 27 work, only a subset of the genomic image features are relevant for predicting prognosis. 28 Thus, to successfully develop a multi-modal model for prognosis prediction, an approach 29 is required that can efficiently work with clinical, genomic and image data, in essence 30 multimodal data. Here, we tackle this challenging problem by developing a pancancer 31 deep learning architecture drawing from unsupervised and representation learning 32 techniques, and developing a resilient learning architecture that exploits large-scale 33 genomic and image data to the fullest extent. 34 The main goal of this contribution is to harness the vast amount of TCGA data 35 available to develop a robust representation of tumor characteristics that can be used to 36 cluster and compare patients across a variety of different metrics. Using unsupervised 37 representation techniques, we develop pancancer survival models for cancer patients 38 using multi-modal data including clinical, genomic and WSI data. 39 Background 40 Prognosis prediction can be formulated as a censored survival analysis problem [8, 9] , 41 predicting both if and when an event (i.e. patient death) occurs within a given time 42 period. Given the unique statistical distribution of survival times, they are canonically 43 parametrized using the "hazard function", such as in standard Cox regression. 44 In recent years, many different approaches have been attempted to predict cancer 45 prognosis using genomic data. For example, Zhang et al., used an augmented Cox 46 regression on TCGA gene expression data to get a C -index of 0.725 in predicting 47 glioblastoma [10] . MicroRNA data in particular have shown high relevance as a measure 48 for disease modeling and prognosis [11] [12] [13] [14] , with Christinat et al., achieving a C-index mechanisms to learn what patches are important [26] . However, in prognosis prediction, 78 truly-automated WSI-based systems have had limited success. One report uses a 79 slide-based approach that relies on unsupervised learning -Zhu et al.'s recent paper 80 uses K-means clustering to characterize and adaptively sample patches within slide 81 images, achieving 0.708 C-index on lung cancer data [27] , a result that nearly rivals 82 genomic-data approaches.
83
All previous research has focused on only single-cancer data sets, missing the 84 opportunity to explore commonalities and relationships between tumors in different 85 tissues. And although previous papers explore both genomic and imaging based 86 approaches, few models have been developed that integrate both data modalities. By 87 exploiting multimodal data, as well as developing better methods to automate WSI 88 scoring and extract useful information from slides, we have the potential to improve 89 upon the state-of-the-art.
90
In recent years, CNNs have been used to significantly improve machine learning 91 tasks [28] including missing value estimation in genomic data [29] and prediction of 92 prognostic factors based on WSI [26] . A key component of the success of CNNs is their 93 ability to deal with high-dimensional, unstructured data, in particular image data [30] . 94 For example, CNNs can accurately classify scenes from images by learning a set of 95 flexible, hierarchical features [31] . Even if the majority of pixel inputs are "dropped out" 96 completely for some samples, this model can still be trained to predict accurately and 97 can handle the uncertainty [32] .
98
The prognosis prediction task is more unstructured than traditional deep learning 99 tasks; instead of classifying from relatively small images (224 by 224 for ImageNet, for 100 example), we must predict survival times from biopsy slides that are much larger.
Materials and Methods

112
Data Sets and Tools
113
Our main source of data is the TCGA database, 114 (http://cancergenome.nih.gov/) [5] [6] [7] , which contains microRNA data for 1,881 115 microRNAs, gene expression data for 60,383 genes, a wide range of clinical data, and 116 WSI data for over 11,000 patients. Table 1 describes the data distribution in more 117 detail. It is clear that many patients do not have all their data available, implying that 118 classifiers and architectures that can deal with missing data might perform better. Each 119 patient has a time of death recorded, right-censored up to a maximum of 11,000 days 120 after diagnosis across all cancer sites. The 20 cancers we examine have significantly 121 different survival patterns, as can be seen in Fig 1. We rely on the Python package 122 openslide to efficiently read and parse WSIs and the PyTorch framework to enable the 123 creation of neural network models. To train our models, we use an NVIDIA™ GTX 1070 124 GPU. In order to train a pancancer model for prognosis prediction, we first attempt to 130 compress multiple data modalities into a single feature vector that represents a patient. 131 Previous work has found significant cross-correlations between different data types (e.g. 132 gene expression, clinical, microRNA and image data) [23, 35] , and learning these 133 relations in an unsupervised fashion could significantly improve the prognosis prediction 134 process. Thus, we use a representation learning framework to guide our approach.
135
Although approaches such as split-brain autoencoders induce convergence between 136 different multimodal feature representations, they rely on reconstruction error, which 137 may not be a good choice for heterogeneous data sources. Instead, we rely on a method 138 inspired by Chopra et al., in which two different "views" of objects are passed through a 139 Siamese network to create feature representations [36] . For views from the same object, 140 the cosine similarity between these feature representations is maximized, whereas for 141 views from different objects, the cosine similarity is minimized. To ensure stability, a representations. This forces different views of a single patient's information to have 145 similar feature vectors, while avoiding mode collapse where all features predict exactly 146 the same vector for all patients.
147
In this work, we use a similar formulation as [36] , but with some modifications.
148
Because of the different data modalities, instead of using a Siamese network, we use one 149 deep neural network for each data type, with differing architectures described in Fig 2. 150
We define the feature space to have a length of 512. Since we have more than two 151 different modalities, we sum over the similarity loss for each pair of modalities that are 152 present. We can define the loss l sim (θ) as in the equations 1, 2 and 3.
153
where x i is the data for modality i andĥ θ,i is the predictive model for modality i.
154
Note that the parameter M controls the "tightness" of the clustering. If M is high, 155 feature vectors for a given patient are permitted to be relatively different, as long as 156 they stay similar to a certain extent. If M is low, feature vectors for a patient are forced 157 to be much closer together, which is usually more ideal, but can also cause mode Structure of the unsupervised model: the similarity loss can be visualized as "pulling" representations of different modalities together. Each modality uses a different network architecture. For the clinical data we use fully connected layers with sigmoid activations, for the genomic data we use deep highway networks [37] and for the WSI images we use the SqueezeNet architecture [38] (see main text for architecture details). These architectures generate feature vectors that are then aggregated into a single representation and used to predict overall survival.
Prognosis Prediction 167
In addition to learning strong feature representations, the model must also accurately 168 predict prognosis. Because this is a survival data problem, we aim to maximize the 169 concordance score or C-index. Previous research has defined the Cox loss function [39] 170 as the best way to maximize concordance differentiably. Thus, we add a final prediction 171 layer that maps the 512 feature vector to a survival prediction. We use the standard
where the values T i , E i and x i are, respectively, the survival time, the censorship 174 flag, and the data for each patient, andĥ θ represents the neural network model trained 175 to predict survival times. The loss is computed over all patients whose lack of survival 176 was observed. Combining with the unsupervised model, the overall loss becomes
Model Architectures
178
We use a dedicated CNN architecture for each data type. For the clinical data, we use 179 fully-connected (FC) layers ( Figure 2) with sigmoid activations and dropout as encoders. 180 For the gene and microRNA data, we use highway networks as the architecture [37] .
181
Because of the complexity and scale of WSI images, we use the CNN architecture to 182 encode the image data. These architectures are now described in more detail.
183
The genomic and microRNA patient data sources are represented by dense, large 184 one-dimensional vectors, and neural networks are not the traditional choice for such 185 problems, for example support vector machines or random forests are more commonly 186 used [40, 41] . However, in order to differentiably optimize the similarity and Cox loss, We tuned the hyperparameters of these model architectures on a validation set to 210 find the final model parameters (Figure 2, Figure 3 ). To evaluate the performance of 211 our model, we use the concordance score (C-index) on the test data set.
212
Multimodal Dropout
213
Dropout is a commonly used regularization technique in deep neural network 214 architectures in which some randomly selected neurons are dropped out during the 215 training, forcing other neurons to step in to make predictions for missing neurons. This 216 technique results in less overfitting and more generalization [42] . For multimodal 217 dropout, instead of dropping neurons, we drop entire feature vectors corresponding to 218 each modality, and scale up the weights of the other modalities correspondingly similar 219 to our previous work [23] . This is applied to each data sample during training with 220 probability p for each modality, to force the network to create representations that are 221 robust to missing data modalities. We experimented with a number of different values 222 for P before settling on 25% as optimal. We first evaluated the unsupervised representation learning of our model architecture by 236 visualizing the encodings of the pancancer patient cohort (Figure 4 ). Clusters of 237 patients with similar feature representations tend to have the same traits (race, sex, and 238 cancer type), even though the model was not explicitly trained on these variables. The 239 CNN model thus learned, in an unsupervised fashion, that factors like sex, race, and 240 cancer type helped to identify and cluster patients across different modalities. These 241 results suggest that the unsupervised model can effectively summarize information from 242 multimodal data paving the way for accurate survival prediction. Perhaps even more 243 importantly, these unsupervised encodings could act as a pancancer "patient profile". Next, we evaluated the use of the multimodal dropout when integrating multi-modal 246 clinical, gene expression, microRNA and WSIs across 20 cancer sites to predict the 247 survival of patients. This analysis showed that the validation C-index improves when 248 using multimodal dropout during training (Fig 5) , indicating that randomly 249 dropping-out feature vectors during training improves the network's ability to build 250 accurate representations from missing data. We train for 80 epochs, however the models 251 appear to converge after 40 epochs. 
Pancancer Prognosis Prediction
253
We then use our model on the test data set to predict prognosis for different cancer 254 types. The model integrating clinical, mRNA, microRNA and WSI achieves an overall 255 C-index of 0.78 on all cancers with multimodal dropout and an overall C-index of 0.75 256 without multimodal dropout ( All previous work on prognosis prediction using genomic and WSI data has focused 288 on specific cancer types and data sets; thus it is difficult to exactly compare our method 289 to previous results. Christinat et al.. achieved the highest C-index (0.77) thus far, on 290 renal cancer data (TCGA-KIRC). As can be seen from the table, our method performed 291 slightly worse (0.740) on the same type of data. But, our method heavily outperforms 292 the only multimodality classifier (0.726 versus 0.691 C-index) on lung 293 adenocarcinoma [24] . In general there is no "fair comparison" that can be made between 294 this method and the previous state-of-the-art, especially because most previous papers 295 discard patients with missing data modalities, but we train and predict with missing 296 data included. Our methods achieve comparable or better results from previous research 297 by resiliently handling incomplete data and predicting across 20 different cancer types. 298
Conclusion 299
In this paper, we demonstrate a multimodal approach for predicting prognosis using 300 clinical, genomic, and WSI data. First, we developed an unsupervised method to encode 301 multimodal patient data into a common feature representation that is independent of 302 data type or modality. We then illustrated that these unsupervised patient encodings 303 are highly predictive of a wide range of useful clinical features, and that patients with 304 similar characteristics tend to cluster together in "representation-space". These feature 305 representations act as an integrated multi-modal patient profile, enabling machine 306 learning models to compare and contrast patients in a systematic fashion. Thus, these 307 encodings could be vitally useful in a number of contexts, ranging from prognosis 308 prediction to treatment recommendation. 309 We then used these feature representations to predict prognosis. On 20 TCGA 310 cancer sites, our methods achieve the overall C-index of 0.784. Furthermore, even on 311 cancer types that have few samples (e.g. KICH), our prognostic prediction model is able 312 to estimate prognosis with relatively high accuracy, leveraging unsupervised features 313 and information from other cancer types to overcome data scarcity.
314
Our research distinguishes itself in a number of ways. It is the first attempt to build 315 a pancancer model of prognosis. Next, we show the use of multimodal data, novel 316 representation learning techniques, and methods such as multimodal dropout to create 317 models that can generalize well and predict also in the absence of one or more data 318 modalities. More specifically, while learning unsupervised relationships between clinical, 319 genomic and image data, our proposed CNN is forced to develop a unique, consistent 320 representation for each patient. Finally, we propose an efficient automated WSI analysis 321 by sampling 40 ROIs per patient representing on average 15% of the non-background 322 space on tissue slides.
323
Future Work
324
Although we have created an algorithm to select patches from WSI images, our results, 325 which showed only significant improvement for select cancer sites, indicates that our 326 method to select ROIs likely can be further improved. Refining the CNN architecture 327 used for encoding the biopsy slides is crucial to further improve the performance.
328
Future research, likely should focus on learning which image patches are important, 329 rather than randomly sampling patches. Furthermore, we can use more advanced, and computing constraints prevented us from exploring other data genomic modalities 336 in TCGA, such as DNA methylation [45, 46] and DNA copy number data [47, 48] , all of 337 which have potentially untapped, prognostically-relevant information. 
